Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea.
Gliclazide is indicated in patients with type 2 diabetes when diet and exercise do not result in adequate glycemic control.
Subject to medical prescription
Pharmaceutical form: 80 mg x 60 film-coated tablets
NHIF code: AF317 ICD: E11.2, E11.3, E11.4, E11.5, E11.9